Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo.
Smooth muscle cell (SMC) proliferation is an important component of restenosis in response to injury after balloon angioplasty. Inhibition of proliferation in vivo can limit neointima hyperplasia in animal models of restenosis. Ribozymes against c-myb mRNA have been shown to be effective inhibitors of SMC proliferation in vitro. The effectiveness of adenovirus as a gene therapy vector in animal models of restenosis is well documented. In order to test the utility of ribozymes to inhibit SMC proliferation by a gene therapy approach, recombinant adenovirus expressing ribozymes against c-myb mRNA was generated and tested both in vitro and in vivo. This adenovirus ribozyme vector is shown to inhibit SMC proliferation in culture and neointima formation in a rat carotid artery balloon injury model of restenosis.
Macejak
D G
DG
Ribozyme Pharmaceuticals, Inc., Boulder, Colorado 80301, USA. macejad@rpi.com
Lin
H
H
Webb
S
S
Chase
J
J
Jensen
K
K
Jarvis
T C
TC
Leiden
J M
JM
Couture
L
L
D000256:Adenoviridae; D000800:Angioplasty, Balloon; D000818:Animals; D002455:Cell Division; D002460:Cell Line; D002478:Cells, Cultured; D015870:Gene Expression; D005822:Genetic Vectors; D006801:Humans; D051379:Mice; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000378:metabolism*; D020598:Proto-Oncogene Proteins c-myb; D016337:RNA, Catalytic / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger; D051381:Rats; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism*
D011518:Proto-Oncogene Proteins; D020598:Proto-Oncogene Proteins c-myb; D016337:RNA, Catalytic; D012333:RNA, Messenger; D015534:Trans-Activators